SPRINT.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 07:07):

Stats
Today's Volume	81 846.00
Average Volume	207 002
Market Cap	94.54M
EPS	SEK0 ( 2024-02-12 )
Next earnings date	( SEK0 ) 2024-05-07
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-135.40
ATR14	SEK0.0240 (1.77%)

Sprint Bioscience AB Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sprint Bioscience AB Financials

Annual	2023
Revenue:	SEK50.49M
Gross Profit:	SEK-3.73M (-7.39 %)
EPS:	SEK-0.00630

Q4	2023
Revenue:	SEK10.88M
Gross Profit:	SEK-5.01M (-46.08 %)
EPS:	SEK-0.0722

Q3	2023
Revenue:	SEK39.57M
Gross Profit:	SEK37.81M (95.56 %)
EPS:	SEK0.410

Q2	2023
Revenue:	SEK41 000.00
Gross Profit:	SEK-1.25M (-3 039.02 %)
EPS:	SEK-0.170

Financial Reports:

No articles found.

Sprint Bioscience AB

Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB (publ) was founded in 2009 and is based in Huddinge, Sweden.